Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Expert Clinical Trial Management for Devices & IVDs

Purpose-built for next-generation devices and IVDs, our innovation-driven model turns breakthrough concepts into market-ready therapies that improve patients’ lives.

Device & IVD Trials: A Different Kind of Rigor

 

Medical-device and IVD investigations must document safety, performance, usability, and human-factors data under ISO 20916 good-study practice for IVDs and ISO 14155 for devices. Europe’s MDR and IVDR demand scientific validity plus analytical and clinical performance evidence for CE-marking, while FDA’s least-burdensome policy lets sponsors exclude non-essential endpoints—if they prove the core claims. Effective clinical trial management therefore balances two regimes at once, aligning U.S. and EU expectations without over-collecting data and increasing study costs.
Veranex engineers protocols that reconcile both frameworks—delivering only the data regulators and payers need, nothing extraneous. 

Veranex CRO

Trial Design Studio × Evidence Integration Engine

Our clinical trial management approach unites cross-functional expertise through real-time collaboration, eliminating traditional gaps between study design and market access. This integrated methodology ensures protocols satisfy both regulatory requirements and payer expectations from day one. The result: streamlined clinical trial management that accelerates approval while building the evidence foundation for successful reimbursement.

Co-create in the Studio

Clinical strategists, regulatory scientists, statisticians, usability engineers, and health-economics experts draft a global protocol in a single sprint.

Co-create in the Studio

Aligns FDA, MDR / IVDR, and payer expectations in a single sprint, giving you a globally accepted and effective protocol from day one.

Learn more

cro-1

Run the Engine

Every endpoint is aligned with approval and coverage criteria for early payer feedback. Leverage regulator feedback channels or our commercialization team’s payer panels.

Run the Engine

Align every endpoint with the standards regulators use for approval and payers use for reimbursement.  Additionally, tap into our commercialization payer panels in 30 + countries, so your data story resonates with both audiences.  

Learn more

cro-2

Stay Efficient & Adaptive

Use Bayesian and frequentist adaptive designs to trim sample size and timelines while preserving study power and integrity.

Stay Efficient & Adaptive

Adaptive designs, supported by US/EU regulators, let us modify enrollment or endpoints based on interim data, so you reach answers faster with fewer participants and uncompromised statistical rigor.  

Learn more

cro-3

Proven Domain Mastery in Device & IVD Trial Management

Leading cardiovascular, neurological, IVD, and ophthalmology innovators trust our clinical trial management expertise because we infuse every protocol with deep therapeutic insight and executional excellence.

home-hear-1

Cardiovascular

As a recognized leader, we accelerate cardiovascular innovation with integrated expertise from concept through commercialization.

neuro

Neurovascular

Collaboration across disciplines ensures neurovascular devices rapidly navigate from design breakthroughs to regulatory approval.

in-vitro

In-Vitro Diagnostics

From analytical performance to clinical utility, our teams deliver on diagnostic study requirements, ensuring your assays deliver patient impact.

home-eyes-1

Ophthalmology

Cross-functional teams optimize ophthalmic device design, clinical trials, and regulatory strategy, delivering clearer vision to market sooner.

cro-left-1

Full-Service or Functional Study Execution

Our flexible clinical trial management model lets you engage Veranex as either a full-service CRO or a functional service provider, scaling precisely the expertise your study needs without adding unnecessary overhead. In full-service mode, we pair your internal team with a dedicated Veranex project lead who oversees every aspect of execution—from regulatory compliance and site monitoring to data collection and reporting—while the functional mode inserts focused specialists into your existing workflows, enabling agile resource shifts and seamless coverage for any gaps.

Discover More

Related Services at Veranex

Trial Design

Trial Design

Optimize study design and sample size so endpoints resonate with regulators and payers alike.

Learn more

hover-card-1

Regulatory Consulting

Regulatory Consulting

Navigate MDR/IVDR and FDA pathways with seasoned specialists who accelerate your path to approval.

Learn more

hover-card-2

Commercialization & Market Access

Commercialization & Market Access

Pair regulatory approval with payer-ready evidence by leveraging reimbursement strategies that synchronize coding, coverage, and pricing.

Learn more

t-2

Human Factors

Human Factors

Minimize use-related hazards and slash recall risk by integrating human factors testing from concept through clinical trials.

Learn more

003

Fuse Expertise + Evidence with Veranex Clinical Trial Management

Secure the right data with the right partner.  Book a consult and see how Veranex fuses expertise and evidence to accelerate both approval and reimbursement